Goede, V., Fischer, K., Engelke, A., Schlag, R., Lepretre, S., Montero, L. F. C., Montillo, M., Fegan, C., Asikanius, E., Humphrey, K., Fingerle-Rowson, G. and Hallek, M. (2015). Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. Leukemia, 29 (7). S. 1602 - 1606. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Goede, V.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fischer, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Engelke, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlag, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lepretre, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Montero, L. F. C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Montillo, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fegan, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Asikanius, E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Humphrey, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fingerle-Rowson, G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hallek, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-400493
DOI: 10.1038/leu.2015.14
Journal or Publication Title: Leukemia
Volume: 29
Number: 7
Page Range: S. 1602 - 1606
Date: 2015
Publisher: NATURE PUBLISHING GROUP
Place of Publication: LONDON
ISSN: 1476-5551
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
INITIAL THERAPY; OPEN-LABEL; IN-VITRO; RITUXIMAB; IBRUTINIB; CYCLOPHOSPHAMIDE; FLUDARABINE; OFATUMUMAB; ANTIBODY; GA101Multiple languages
Oncology; HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/40049

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item